Logo image of CMRE

COSTAMARE INC (CMRE) Stock Fundamental Analysis

NYSE:CMRE - New York Stock Exchange, Inc. - MHY1771G1026 - Common Stock

11.92  -0.12 (-1%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CMRE. CMRE was compared to 29 industry peers in the Marine Transportation industry. CMRE has an average financial health and profitability rating. CMRE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CMRE had positive earnings in the past year.
CMRE had a positive operating cash flow in the past year.
CMRE had positive earnings in 4 of the past 5 years.
CMRE had a positive operating cash flow in each of the past 5 years.
CMRE Yearly Net Income VS EBIT VS OCF VS FCFCMRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M

1.2 Ratios

CMRE has a Return On Assets (6.82%) which is comparable to the rest of the industry.
The Return On Equity of CMRE (14.37%) is better than 64.29% of its industry peers.
CMRE has a Return On Invested Capital of 7.60%. This is in the better half of the industry: CMRE outperforms 60.71% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CMRE is in line with the industry average of 8.54%.
Industry RankSector Rank
ROA 6.82%
ROE 14.37%
ROIC 7.6%
ROA(3y)8.86%
ROA(5y)5.62%
ROE(3y)20.85%
ROE(5y)13.15%
ROIC(3y)7.75%
ROIC(5y)6.8%
CMRE Yearly ROA, ROE, ROICCMRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

CMRE has a Profit Margin of 17.61%. This is comparable to the rest of the industry: CMRE outperforms 42.86% of its industry peers.
CMRE's Profit Margin has improved in the last couple of years.
CMRE has a Operating Margin of 21.51%. This is comparable to the rest of the industry: CMRE outperforms 42.86% of its industry peers.
In the last couple of years the Operating Margin of CMRE has declined.
Looking at the Gross Margin, with a value of 35.06%, CMRE is doing worse than 67.86% of the companies in the same industry.
CMRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 21.51%
PM (TTM) 17.61%
GM 35.06%
OM growth 3Y-15.39%
OM growth 5Y-5.76%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-16.82%
GM growth 5Y-9.69%
CMRE Yearly Profit, Operating, Gross MarginsCMRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CMRE is still creating some value.
CMRE has less shares outstanding than it did 1 year ago.
CMRE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CMRE has an improved debt to assets ratio.
CMRE Yearly Shares OutstandingCMRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CMRE Yearly Total Debt VS Total AssetsCMRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

CMRE has an Altman-Z score of 1.42. This is a bad value and indicates that CMRE is not financially healthy and even has some risk of bankruptcy.
CMRE has a Altman-Z score (1.42) which is in line with its industry peers.
CMRE has a debt to FCF ratio of 4.87. This is a neutral value as CMRE would need 4.87 years to pay back of all of its debts.
CMRE's Debt to FCF ratio of 4.87 is fine compared to the rest of the industry. CMRE outperforms 60.71% of its industry peers.
CMRE has a Debt/Equity ratio of 0.75. This is a neutral value indicating CMRE is somewhat dependend on debt financing.
CMRE's Debt to Equity ratio of 0.75 is on the low side compared to the rest of the industry. CMRE is outperformed by 60.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 4.87
Altman-Z 1.42
ROIC/WACC1.02
WACC7.48%
CMRE Yearly LT Debt VS Equity VS FCFCMRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.65 indicates that CMRE should not have too much problems paying its short term obligations.
The Current ratio of CMRE (1.65) is comparable to the rest of the industry.
CMRE has a Quick Ratio of 1.56. This is a normal value and indicates that CMRE is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.56, CMRE perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.56
CMRE Yearly Current Assets VS Current LiabilitesCMRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

CMRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.31%, which is quite impressive.
CMRE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 37.06% yearly.
The Revenue has grown by 58.38% in the past year. This is a very strong growth!
Measured over the past years, CMRE shows a very strong growth in Revenue. The Revenue has been growing by 31.77% on average per year.
EPS 1Y (TTM)37.31%
EPS 3Y26.81%
EPS 5Y37.06%
EPS Q2Q%47.83%
Revenue 1Y (TTM)58.38%
Revenue growth 3Y48.63%
Revenue growth 5Y31.77%
Sales Q2Q%14.45%

3.2 Future

Based on estimates for the next years, CMRE will show a small growth in Earnings Per Share. The EPS will grow by 5.06% on average per year.
CMRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.69% yearly.
EPS Next Y38.53%
EPS Next 2Y20.07%
EPS Next 3Y5.06%
EPS Next 5YN/A
Revenue Next Year34.05%
Revenue Next 2Y5.53%
Revenue Next 3Y0.69%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CMRE Yearly Revenue VS EstimatesCMRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
CMRE Yearly EPS VS EstimatesCMRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

CMRE is valuated cheaply with a Price/Earnings ratio of 4.32.
CMRE's Price/Earnings ratio is in line with the industry average.
CMRE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.29.
A Price/Forward Earnings ratio of 3.97 indicates a rather cheap valuation of CMRE.
67.86% of the companies in the same industry are more expensive than CMRE, based on the Price/Forward Earnings ratio.
CMRE is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.32
Fwd PE 3.97
CMRE Price Earnings VS Forward Price EarningsCMRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CMRE.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CMRE indicates a somewhat cheap valuation: CMRE is cheaper than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.16
EV/EBITDA 4.51
CMRE Per share dataCMRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.11
PEG (5Y)0.12
EPS Next 2Y20.07%
EPS Next 3Y5.06%

5

5. Dividend

5.1 Amount

CMRE has a Yearly Dividend Yield of 3.73%.
CMRE's Dividend Yield is comparable with the industry average which is at 9.88.
Compared to an average S&P500 Dividend Yield of 2.28, CMRE pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.73%

5.2 History

The dividend of CMRE has a limited annual growth rate of 5.41%.
CMRE has paid a dividend for at least 10 years, which is a reliable track record.
CMRE has decreased its dividend recently.
Dividend Growth(5Y)5.41%
Div Incr Years0
Div Non Decr Years1
CMRE Yearly Dividends per shareCMRE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

20.19% of the earnings are spent on dividend by CMRE. This is a low number and sustainable payout ratio.
The dividend of CMRE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP20.19%
EPS Next 2Y20.07%
EPS Next 3Y5.06%
CMRE Yearly Income VS Free CF VS DividendCMRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M
CMRE Dividend Payout.CMRE Dividend Payout, showing the Payout Ratio.CMRE Dividend Payout.PayoutRetained Earnings

COSTAMARE INC

NYSE:CMRE (1/22/2025, 10:41:58 AM)

11.92

-0.12 (-1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryMarine Transportation
Earnings (Last)11-01 2024-11-01/bmo
Earnings (Next)02-04 2025-02-04/amc
Inst Owners26.99%
Inst Owner Change0.03%
Ins Owners64.11%
Ins Owner ChangeN/A
Market Cap1.43B
Analysts45.71
Price Target14.28 (19.8%)
Short Float %3.94%
Short Ratio5.92
Dividend
Industry RankSector Rank
Dividend Yield 3.73%
Yearly Dividend0.6
Dividend Growth(5Y)5.41%
DP20.19%
Div Incr Years0
Div Non Decr Years1
Ex-Date01-21 2025-01-21 (0.12)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.87%
Min EPS beat(2)4.17%
Max EPS beat(2)5.58%
EPS beat(4)3
Avg EPS beat(4)3.06%
Min EPS beat(4)-4.98%
Max EPS beat(4)7.47%
EPS beat(8)5
Avg EPS beat(8)-1.07%
EPS beat(12)8
Avg EPS beat(12)-0.52%
EPS beat(16)11
Avg EPS beat(16)0.24%
Revenue beat(2)2
Avg Revenue beat(2)39.2%
Min Revenue beat(2)30.49%
Max Revenue beat(2)47.91%
Revenue beat(4)4
Avg Revenue beat(4)32.67%
Min Revenue beat(4)20.32%
Max Revenue beat(4)47.91%
Revenue beat(8)7
Avg Revenue beat(8)26.02%
Revenue beat(12)9
Avg Revenue beat(12)17.09%
Revenue beat(16)9
Avg Revenue beat(16)12.34%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.37%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)16.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)11.71%
Valuation
Industry RankSector Rank
PE 4.32
Fwd PE 3.97
P/S 0.7
P/FCF 3.16
P/OCF 2.54
P/B 0.57
P/tB 0.57
EV/EBITDA 4.51
EPS(TTM)2.76
EY23.15%
EPS(NY)3
Fwd EY25.16%
FCF(TTM)3.77
FCFY31.6%
OCF(TTM)4.69
OCFY39.33%
SpS16.95
BVpS20.77
TBVpS20.77
PEG (NY)0.11
PEG (5Y)0.12
Profitability
Industry RankSector Rank
ROA 6.82%
ROE 14.37%
ROCE 9.62%
ROIC 7.6%
ROICexc 9.39%
ROICexgc 9.39%
OM 21.51%
PM (TTM) 17.61%
GM 35.06%
FCFM 22.23%
ROA(3y)8.86%
ROA(5y)5.62%
ROE(3y)20.85%
ROE(5y)13.15%
ROIC(3y)7.75%
ROIC(5y)6.8%
ROICexc(3y)9.1%
ROICexc(5y)7.73%
ROICexgc(3y)9.1%
ROICexgc(5y)7.73%
ROCE(3y)9.81%
ROCE(5y)8.61%
ROICexcg growth 3Y11.54%
ROICexcg growth 5Y16.02%
ROICexc growth 3Y11.54%
ROICexc growth 5Y16.02%
OM growth 3Y-15.39%
OM growth 5Y-5.76%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-16.82%
GM growth 5Y-9.69%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 4.87
Debt/EBITDA 3.09
Cap/Depr 67.19%
Cap/Sales 5.44%
Interest Coverage 2.93
Cash Conversion 93.45%
Profit Quality 126.23%
Current Ratio 1.65
Quick Ratio 1.56
Altman-Z 1.42
F-Score7
WACC7.48%
ROIC/WACC1.02
Cap/Depr(3y)270.55%
Cap/Depr(5y)192%
Cap/Sales(3y)45.36%
Cap/Sales(5y)34.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.31%
EPS 3Y26.81%
EPS 5Y37.06%
EPS Q2Q%47.83%
EPS Next Y38.53%
EPS Next 2Y20.07%
EPS Next 3Y5.06%
EPS Next 5YN/A
Revenue 1Y (TTM)58.38%
Revenue growth 3Y48.63%
Revenue growth 5Y31.77%
Sales Q2Q%14.45%
Revenue Next Year34.05%
Revenue Next 2Y5.53%
Revenue Next 3Y0.69%
Revenue Next 5YN/A
EBIT growth 1Y20.84%
EBIT growth 3Y25.75%
EBIT growth 5Y24.19%
EBIT Next Year43.73%
EBIT Next 3Y7.1%
EBIT Next 5YN/A
FCF growth 1Y105.51%
FCF growth 3Y12.87%
FCF growth 5YN/A
OCF growth 1Y-9.78%
OCF growth 3Y6.5%
OCF growth 5Y18.67%